PetMed Express, Inc.
PETS
$2.74
-$0.01-0.36%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -21.95% | -18.88% | -16.10% | -13.15% | -4.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -21.95% | -18.88% | -16.10% | -13.15% | -4.60% |
| Cost of Revenue | -21.90% | -19.73% | -17.04% | -10.30% | -21.74% |
| Gross Profit | -22.02% | -16.63% | -13.71% | -20.22% | 39.78% |
| SG&A Expenses | 20.38% | -28.22% | -15.26% | -52.38% | 53.83% |
| Depreciation & Amortization | 9.45% | -10.40% | -3.21% | 2.56% | 90.64% |
| Other Operating Expenses | -8.27% | -- | -- | -- | -416.28% |
| Total Operating Expenses | -3.91% | -21.87% | -16.26% | -21.72% | -2.15% |
| Operating Income | -502.07% | 85.36% | -3.48% | 564.37% | -250.33% |
| Income Before Tax | -71.90% | 90.85% | -27.73% | 429.97% | -868.21% |
| Income Tax Expenses | 268.62% | 175.24% | -347.96% | 428.08% | 129.60% |
| Earnings from Continuing Operations | -132.14% | 65.12% | 225.31% | 430.46% | -2,222.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -132.14% | 65.12% | 225.31% | 430.46% | -2,222.22% |
| EBIT | -502.07% | 85.36% | -3.48% | 564.37% | -250.33% |
| EBITDA | -771.99% | 187.12% | -3.30% | 1,583.07% | -416.49% |
| EPS Basic | -129.91% | 65.42% | 221.65% | 427.37% | -2,215.09% |
| Normalized Basic EPS | -613.31% | 90.98% | -6.05% | 1,226.22% | -3,105.56% |
| EPS Diluted | -126.13% | 65.70% | 266.67% | 400.00% | -2,253.77% |
| Normalized Diluted EPS | -613.31% | 90.98% | -5.66% | 1,203.05% | -3,105.56% |
| Average Basic Shares Outstanding | 0.95% | 1.03% | 1.05% | 0.89% | 0.56% |
| Average Diluted Shares Outstanding | 0.95% | 1.03% | 0.76% | 3.00% | 0.51% |
| Dividend Per Share | -- | -- | -- | -- | -100.00% |
| Payout Ratio | 0.88% | 0.81% | -1.00% | 1.01% | 1.00% |